CEL-SCI CORPORATION Net Income
CEL-SCI CORPORATION (CVM) reported Net Income of -$5.67 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-14
- CEL-SCI CORPORATION net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$5.67M.
- CEL-SCI CORPORATION net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$5.47M.
- CEL-SCI CORPORATION net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$5.47M.
- CEL-SCI CORPORATION net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$6.10M.
- CEL-SCI CORPORATION net income (loss) attributable to parent for fiscal 2025 was -$25.41M.
- CEL-SCI CORPORATION net income (loss) attributable to parent for fiscal 2024 was -$26.92M.
- CEL-SCI CORPORATION net income (loss) attributable to parent for fiscal 2023 was -$32.37M.
- CEL-SCI CORPORATION net income (loss) attributable to parent for fiscal 2022 was -$36.70M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.67M 10-Q · filed 2026-08-14 | -$11.13M derived: sum of 2 quarters · filed 2026-08-14 | -$16.60M 10-Q · filed 2026-08-14 | -$22.70M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | -$5.47M 10-Q · filed 2026-08-14 | -$10.94M 10-Q · filed 2026-05-15 | -$17.04M derived: sum of 3 quarters · filed 2026-08-14 | -$22.70M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$5.47M 10-Q · filed 2026-08-14 | -$11.57M derived: sum of 2 quarters · filed 2026-08-14 | -$17.24M derived: sum of 3 quarters · filed 2026-08-14 | -$23.81M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-09-30 | -$6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | -$11.77M derived: sum of 2 quarters · filed 2026-08-14 | -$18.34M derived: sum of 3 quarters · filed 2026-08-14 | -$25.41M 10-K · filed 2025-12-29 | ||||
| 2025-06-30 | -$5.66M 10-Q · filed 2026-08-14 | -$12.24M derived: sum of 2 quarters · filed 2026-08-14 | -$19.31M 10-Q · filed 2026-08-14 | -$25.42M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | -$6.57M 10-Q · filed 2026-08-14 | -$13.65M 10-Q · filed 2026-05-15 | -$19.75M derived: sum of 3 quarters · filed 2026-08-14 | -$26.61M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2024-12-31 | -$7.07M 10-Q · filed 2026-08-14 | -$13.18M derived: sum of 2 quarters · filed 2026-08-14 | -$20.04M derived: sum of 3 quarters · filed 2026-08-14 | -$27.28M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2024-09-30 | -$6.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | -$12.97M derived: sum of 2 quarters · filed 2025-12-29 | -$20.21M derived: sum of 3 quarters · filed 2025-12-29 | -$26.92M 10-K · filed 2025-12-29 | -$27.58M 10-K · filed 2025-01-13 | |||
| 2024-06-30 | -$6.86M 10-Q · filed 2025-08-14 | -$14.10M derived: sum of 2 quarters · filed 2025-08-14 | -$20.81M 10-Q · filed 2025-08-14 | -$28.61M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$7.24M 10-Q · filed 2025-08-14 | -$13.95M 10-Q · filed 2025-05-14 | -$21.76M derived: sum of 3 quarters · filed 2025-08-14 | -$30.12M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2023-12-31 | -$6.71M 10-Q · filed 2025-08-14 | -$14.51M derived: sum of 2 quarters · filed 2025-08-14 | -$22.88M derived: sum of 3 quarters · filed 2025-08-14 | -$31.22M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2023-09-30 | -$7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-13 | -$16.17M derived: sum of 2 quarters · filed 2025-01-13 | -$24.51M derived: sum of 3 quarters · filed 2025-01-13 | -$32.37M 10-K · filed 2025-01-13 | -$32.19M 10-K · filed 2023-12-21 | |||
| 2023-06-30 | -$8.37M 10-Q · filed 2024-08-14 | -$16.71M derived: sum of 2 quarters · filed 2024-08-14 | -$24.56M 10-Q · filed 2024-08-14 | -$33.03M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$8.34M 10-Q · filed 2024-08-14 | -$16.20M 10-Q · filed 2024-05-15 | -$24.66M derived: sum of 3 quarters · filed 2024-08-14 | -$34.29M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2022-12-31 | -$7.85M 10-Q · filed 2024-08-14 | -$16.32M derived: sum of 2 quarters · filed 2024-08-14 | -$25.95M derived: sum of 3 quarters · filed 2024-08-14 | -$35.77M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2022-09-30 | -$8.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-21 | -$18.09M derived: sum of 2 quarters · filed 2023-12-21 | -$27.92M derived: sum of 3 quarters · filed 2023-12-21 | -$36.70M 10-K · filed 2023-12-21 | ||||
| 2022-06-30 | -$9.63M 10-Q · filed 2023-08-10 | -$19.46M derived: sum of 2 quarters · filed 2023-08-10 | -$28.24M 10-Q · filed 2023-08-10 | -$36.44M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$9.82M 10-Q · filed 2023-08-10 | -$18.61M 10-Q · filed 2023-05-12 | -$26.81M derived: sum of 3 quarters · filed 2023-08-10 | -$35.75M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2021-12-31 | -$8.78M 10-Q · filed 2023-08-10 | -$16.99M derived: sum of 2 quarters · filed 2023-08-10 | -$25.93M derived: sum of 3 quarters · filed 2023-08-10 | -$37.21M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2021-09-30 | -$8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-27 | -$17.14M derived: sum of 2 quarters · filed 2022-12-27 | -$28.42M derived: sum of 3 quarters · filed 2022-12-27 | -$36.36M 10-K · filed 2022-12-27 | ||||
| 2021-06-30 | -$8.94M 10-Q · filed 2022-08-12 | -$20.22M derived: sum of 2 quarters · filed 2022-08-12 | -$28.16M 10-Q · filed 2022-08-12 | -$33.54M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$11.28M 10-Q · filed 2022-08-12 | -$19.22M 10-Q · filed 2022-05-13 | -$24.60M derived: sum of 3 quarters · filed 2022-08-12 | -$34.87M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2020-12-31 | -$7.94M 10-Q · filed 2022-08-12 | -$13.32M derived: sum of 2 quarters · filed 2022-08-12 | -$23.59M derived: sum of 3 quarters · filed 2022-08-12 | -$32.66M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2020-09-30 | -$5.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-21 | -$15.66M derived: sum of 2 quarters · filed 2021-12-21 | -$24.72M derived: sum of 3 quarters · filed 2021-12-21 | -$30.26M 10-K · filed 2021-12-21 | ||||
| 2020-06-30 | -$10.28M 10-Q · filed 2021-08-13 | -$10.22M 10-Q/A · filed 2020-08-11 | -$19.34M derived: sum of 2 quarters · filed 2021-08-13 | -$24.88M 10-Q · filed 2021-08-13 | -$24.71M 10-Q/A · filed 2020-08-11 | -$29.72M derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | -$9.07M 10-Q · filed 2021-08-13 | -$9.01M 10-Q · filed 2020-05-08 | -$14.60M 10-Q/A · filed 2020-12-30 | -$14.49M 10-Q · filed 2020-05-08 | -$19.45M derived: sum of 3 quarters · filed 2021-08-13 | -$31.53M derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2019-12-31 | -$5.53M 10-Q · filed 2021-08-13 | -$5.48M 10-Q · filed 2020-02-10 | -$10.38M derived: sum of 2 quarters · filed 2021-08-13 | -$22.46M derived: sum of 3 quarters · filed 2021-08-13 | -$28.91M derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2019-09-30 | -$4.85M derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-12-29 | -$16.93M derived: sum of 2 quarters · filed 2020-12-31 | -$23.38M derived: sum of 3 quarters · filed 2020-12-31 | -$22.13M 10-K · filed 2020-12-29 | ||||
| 2019-06-30 | -$12.08M 10-Q/A · filed 2020-12-31 | -$18.53M derived: sum of 2 quarters · filed 2020-12-31 | -$17.29M 10-Q/A · filed 2020-12-31 | -$32.21M derived: sum of 4 quarters · filed 2020-12-31 | ||||
| 2019-03-31 | -$6.45M 10-Q/A · filed 2020-12-31 | -$5.20M 10-Q/A · filed 2020-12-30 | -$20.13M derived: sum of 3 quarters · filed 2020-12-31 | -$26.14M derived: sum of 4 quarters · filed 2020-12-31 | ||||
| 2018-12-31 | $1.25M 10-Q/A · filed 2020-12-31 | -$13.68M derived: sum of 2 quarters · filed 2020-12-31 | -$19.70M derived: sum of 3 quarters · filed 2020-12-31 | -$24.40M derived: sum of 4 quarters · filed 2020-12-31 | ||||
| 2018-09-30 | -$14.93M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-23 | -$20.94M derived: sum of 2 quarters · filed 2019-12-23 | -$25.65M derived: sum of 3 quarters · filed 2019-12-23 | -$31.84M 10-K/A · filed 2019-12-23 | ||||
| 2018-06-30 | -$6.01M 10-Q · filed 2019-08-14 | -$10.72M derived: sum of 2 quarters · filed 2019-08-14 | -$16.91M 10-Q · filed 2019-08-14 | -$21.90M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | -$4.71M 10-Q · filed 2019-08-14 | -$10.90M 10-Q · filed 2019-05-14 | -$15.89M derived: sum of 3 quarters · filed 2019-08-14 | -$20.35M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2017-12-31 | -$6.19M 10-Q · filed 2019-08-14 | -$11.18M derived: sum of 2 quarters · filed 2019-08-14 | -$15.65M derived: sum of 3 quarters · filed 2019-08-14 | -$24.07M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2017-09-30 | -$4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-19 | -$9.46M derived: sum of 2 quarters · filed 2018-12-19 | -$17.88M derived: sum of 3 quarters · filed 2018-12-19 | -$14.36M 10-K · filed 2018-12-19 | ||||
| 2017-06-30 | -$4.46M 10-Q · filed 2018-08-14 | -$4.45M 10-Q · filed 2017-08-09 | -$12.89M derived: sum of 2 quarters · filed 2018-08-14 | -$9.37M 10-Q · filed 2018-08-14 | -$9.32M 10-Q · filed 2017-08-09 | -$10.50M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | -$8.43M 10-Q · filed 2018-05-15 | -$8.41M 10-Q · filed 2017-05-10 | -$4.91M 10-Q · filed 2018-05-15 | -$4.87M 10-Q · filed 2017-05-10 | -$6.03M derived: sum of 3 quarters · filed 2018-05-15 | -$9.90M derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $3.52M 10-Q · filed 2018-02-12 | $3.54M 10-Q · filed 2017-02-09 | $2.39M derived: sum of 2 quarters · filed 2018-02-12 | -$1.47M derived: sum of 3 quarters · filed 2018-02-12 | -$10.32M derived: sum of 4 quarters · filed 2018-02-12 | |||
| 2016-09-30 | -$1.13M derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-12-29 | -$4.99M derived: sum of 2 quarters · filed 2017-12-29 | -$13.85M derived: sum of 3 quarters · filed 2017-12-29 | -$11.51M 10-K · filed 2017-12-29 | -$11.47M 10-K · filed 2016-12-15 | |||
| 2016-06-30 | -$3.86M 10-Q/A · filed 2017-12-11 | -$3.85M 10-Q · filed 2016-08-09 | -$12.72M derived: sum of 2 quarters · filed 2017-12-11 | -$10.38M 10-Q/A · filed 2017-12-11 | -$10.35M 10-Q · filed 2016-08-09 | -$20.25M derived: sum of 4 quarters · filed 2017-12-11 | ||
| 2016-03-31 | -$8.86M 10-Q/A · filed 2017-12-11 | -$8.84M 10-Q · filed 2016-05-10 | -$6.52M 10-Q/A · filed 2017-12-11 | -$6.50M 10-Q · filed 2016-05-10 | -$16.38M derived: sum of 3 quarters · filed 2017-12-11 | -$20.81M derived: sum of 4 quarters · filed 2017-12-11 | ||
| 2015-12-31 | $2.33M 10-Q/A · filed 2017-12-11 | $2.34M 10-Q · filed 2016-02-09 | -$7.53M derived: sum of 2 quarters · filed 2017-12-11 | -$11.96M derived: sum of 3 quarters · filed 2017-12-11 | -$24.51M derived: sum of 4 quarters · filed 2017-12-11 | |||
| 2015-09-30 | -$9.86M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | -$14.29M derived: sum of 2 quarters · filed 2017-12-11 | -$26.85M derived: sum of 3 quarters · filed 2017-12-11 | -$34.69M 10-K/A · filed 2017-12-11 | -$34.67M 10-K · filed 2015-12-11 | |||
| 2015-06-30 | -$4.43M 10-Q · filed 2016-08-09 | -$16.99M derived: sum of 2 quarters · filed 2016-08-09 | -$24.83M 10-Q · filed 2016-08-09 | -$32.05M derived: sum of 4 quarters · filed 2016-08-09 | ||||
| 2015-03-31 | -$12.56M 10-Q · filed 2016-05-10 | -$20.40M 10-Q · filed 2016-05-10 | -$27.62M derived: sum of 3 quarters · filed 2016-05-10 | -$30.07M derived: sum of 4 quarters · filed 2016-05-10 | ||||
| 2014-12-31 | -$7.85M 10-Q · filed 2016-02-09 | -$15.07M derived: sum of 2 quarters · filed 2016-02-09 | -$17.51M derived: sum of 3 quarters · filed 2016-02-09 | -$30.88M derived: sum of 4 quarters · filed 2016-02-09 | ||||
| 2014-09-30 | -$7.22M 10-K · filed 2015-12-11 | -$9.67M derived: sum of 2 quarters · filed 2015-12-11 | -$23.03M derived: sum of 3 quarters · filed 2015-12-11 | -$27.35M 10-K/A · filed 2017-12-11 | -$27.37M 10-K · filed 2014-12-23 | |||
| 2014-06-30 | -$2.44M 10-K · filed 2015-12-11 | -$15.81M derived: sum of 2 quarters · filed 2015-12-11 | -$20.14M 10-Q · filed 2015-08-07 | -$21.84M derived: sum of 4 quarters · filed 2015-12-11 | ||||
| 2014-03-31 | -$13.37M 10-K · filed 2015-12-11 | -$17.70M 10-Q · filed 2015-05-08 | -$19.40M derived: sum of 3 quarters · filed 2015-12-11 | -$23.85M derived: sum of 4 quarters · filed 2015-12-11 | ||||
| 2013-12-31 | -$4.33M 10-K · filed 2015-12-11 | -$6.03M derived: sum of 2 quarters · filed 2015-12-11 | -$10.48M derived: sum of 3 quarters · filed 2015-12-11 | -$11.20M derived: sum of 4 quarters · filed 2015-12-11 | ||||
| 2013-09-30 | -$1.70M 10-K · filed 2014-12-23 | -$6.15M derived: sum of 2 quarters · filed 2014-12-23 | -$6.86M derived: sum of 3 quarters · filed 2014-12-23 | -$9.17M 10-K · filed 2015-12-11 | ||||
| 2013-06-30 | -$4.45M 10-K · filed 2014-12-23 | -$5.16M derived: sum of 2 quarters · filed 2014-12-23 | -$7.47M 10-Q · filed 2014-08-08 | -$10.04M derived: sum of 4 quarters · filed 2014-12-23 | ||||
| 2013-03-31 | -$713.37K 10-K · filed 2014-12-23 | -$3.02M 10-Q · filed 2014-05-12 | -$5.59M derived: sum of 3 quarters · filed 2014-12-23 | -$6.43M derived: sum of 4 quarters · filed 2014-12-23 | ||||
| 2012-12-31 | -$2.31M 10-K · filed 2014-12-23 | -$4.88M derived: sum of 2 quarters · filed 2014-12-23 | -$5.71M derived: sum of 3 quarters · filed 2014-12-23 | -$14.21M derived: sum of 4 quarters · filed 2014-12-23 | ||||
| 2012-09-30 | -$2.57M 10-K · filed 2013-12-27 | -$3.40M derived: sum of 2 quarters · filed 2013-12-27 | -$11.90M derived: sum of 3 quarters · filed 2013-12-27 | -$15.48M 10-K · filed 2014-12-23 | ||||
| 2012-06-30 | -$835.45K 10-K · filed 2013-12-27 | -$9.33M derived: sum of 2 quarters · filed 2013-12-27 | -$12.91M 10-Q · filed 2013-08-09 | -$15.23M derived: sum of 4 quarters · filed 2013-12-27 | ||||
| 2012-03-31 | -$8.49M 10-K · filed 2013-12-27 | -$12.08M 10-Q · filed 2013-05-10 | -$14.39M derived: sum of 3 quarters · filed 2013-12-27 | -$17.51M derived: sum of 4 quarters · filed 2013-12-27 | ||||
| 2011-12-31 | -$3.58M 10-K · filed 2013-12-27 | -$5.90M derived: sum of 2 quarters · filed 2013-12-27 | -$9.01M derived: sum of 3 quarters · filed 2013-12-27 | -$23.04M derived: sum of 4 quarters · filed 2013-12-27 | ||||
| 2011-09-30 | -$2.32M 10-K · filed 2012-12-14 | -$5.43M derived: sum of 2 quarters · filed 2012-12-14 | -$19.46M derived: sum of 3 quarters · filed 2012-12-14 | -$25.71M 10-K · filed 2013-12-27 | ||||
| 2011-06-30 | -$3.11M 10-K · filed 2012-12-14 | -$17.14M derived: sum of 2 quarters · filed 2012-12-14 | -$23.39M 10-Q · filed 2012-08-09 | -$30.73M derived: sum of 4 quarters · filed 2012-12-14 | ||||
| 2011-03-31 | -$14.03M 10-K · filed 2012-12-14 | -$20.28M 10-Q · filed 2012-05-10 | -$27.61M derived: sum of 3 quarters · filed 2012-12-14 | -$28.21M derived: sum of 4 quarters · filed 2012-12-14 | ||||
| 2010-12-31 | -$6.25M 10-K · filed 2012-12-14 | -$13.58M derived: sum of 2 quarters · filed 2012-12-14 | -$14.18M derived: sum of 3 quarters · filed 2012-12-14 | |||||
| 2010-09-30 | -$7.33M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-14 | -$7.93M derived: sum of 2 quarters · filed 2012-12-14 | $10.48M 10-K · filed 2012-12-14 | |||||
| 2010-06-30 | -$601.12K 10-Q · filed 2011-08-09 | $17.81M 10-Q · filed 2011-08-09 | ||||||
| 2009-09-30 | -$40.91M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |